bioAffinity Technologies Other 8-K Filing
bioAffinity Technologies received a Notice of Allowance from the Japan Patent Office for a patent covering its CyPath Lung test, a noninvasive diagnostic for early-stage lung cancer. This marks the company's first AI-algorithm-related patent in Japan and its fifth patent in the Asian market. The patent protects the company's proprietary method of using automated flow cytometry and machine learning to predict lung cancer likelihood.
- Counterparty
- Japan Patent Office